2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on R/R Indolent Lymphoma: Is Anti-CD19 CAR-T Axi-cel a Promising Therapeutic Approach for Patients With R/R iNHL?

117 views
August 6, 2020
Comments 0
Login to view comments. Click here to Login